Publications by authors named "Anne E Berger"
Article Synopsis
- The study assesses the new i-TRACK chemiluminescent instrument for monitoring biological TNF inhibitors in patients, comparing its performance to traditional ELISA methods in gastroenterology.
- Intra- and inter-run performance metrics were found to be satisfactory, with i-TRACK often yielding higher values for drug and antibody measurements compared to manual ELISA.
- While i-TRACK shows potential for routine use due to its rapidity and usability, it is recommended to use the same assay consistently in patient follow-ups due to some discrepancies in quantitative results.
Unlabelled: The new subcutaneous (sc) formulation of the infliximab (IFX) biosimilar CT-P13 results in homogeneous serum trough concentrations of IFX at steady state. The present study aimed to investigate in Crohn's disease (CD) patients the intra-individual variations of IFX drug levels at multiple time-points during 2 consecutive cycles of maintenance therapy with CT-P13 sc.
Patients And Methods: CD patients in clinico-biological remission under maintenance therapy with intravenous (iv) IFX/CT-P13 were switched to CT-P13 sc 8 weeks (W) after the last infusion.